TrialBMC medicine2026

Impact of hepatotoxicity and lipid metabolism-related toxicity on survival and quality of life in patients with high-volume metastatic hormone-sensitive prostate cancer treated with rezvilutamide in the CHART trial: a post hoc analysis.

Jun-Long Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.